Home
The Department of Biomedicine

News archive for The Department of Biomedicine

Thomas Arnesen is one of five Norwegian researchers who will receive a prestigious consolidator grant from the European Research Council in 2017.
Researchers at the Department of Biomedicine participate in an international research project that has now found a promising compound which could turn into an effective drug against malaria.
Bortezomib as chemosensitizer for glioblastoma patients with unmethylated MGMT promoter: Phase IB/II clinical trial and mechanisms of therapeutic efficacy
Doctoral candidates from around the world have gathered to communicate their research on the retina. The result is an interactive eye exhibit at VilVite Science Center.
A new study performed at UiB shows that the blood-thinning drug warfarin may prevent the development of cancer
Gry Sandvik Haaland defends her dissertation “Investigations of the cancer therapeutic and protective effects of warfarin mediated inhibition of the receptor tyrosine kinase AXL”